Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Paediatric Multiple Sclerosis Group Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator J Burman, K Kirgizov
RACE: A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients Group Severe Aplastic Anaemia Working Party (SAAWP) Type of transplant Principal investigator Antonio Risitano, Regis Peffault de Latour
A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Type of transplant Principal investigator
Resistance pattern of Gram-negative bacteria isolated from blood from HSCT recipients Group Infectious Diseases Working Party (IDWP) Type of transplant Principal investigator Dina Averbuch
LYM1: Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Group Lymphoma Working Party (LWP) Type of transplant Principal investigator Ruth Pettengell
ASTIMS: High dose immunoablation and autologous haematopoietic stem cell transplantation versus mitoxantrone therapy in severe multiple sclerosis Group Autoimmune Diseases Working Party (ADWP) Type of transplant Principal investigator G.L. Mancardi
Incidence and outcome of pregnancy following stem cell transplantation Group Transplant Complications Working Party (TCWP) Type of transplant Principal investigator Nina Salooja
A Cross-sectional study on the Sexual Function of Adult Survivors and their partners 3 and 15 years Post allogeneic Stem Cell Transplantation Group Transplant Complications Working Party (TCWP) Nursing Research Committee Type of transplant Principal investigator Corien Eeltink, Jacqui Stringer
Autologous Stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study across Europe Group Autoimmune Diseases Working Party (ADWP) Type of transplant Principal investigator Ina Koetter
Observational study on the use of B cell receptor kinase inhibitors and BCL2 antagonists prior to allogeneic hematopoietic stem cell transplantation for B cell malignancies: A joint project of the EBMT Lymphoma and Chronic Malignancy Working Parties. Group Chronic Malignancies Working Party (CMWP) Lymphoma Working Party (LWP) Type of transplant Principal investigator Peter Dreger, Johannes Schetelig
RICMAC: Dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation in patients with MDS or sAML: A randomised phase III study Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Nicolaus Kröger
MMVAR: A Randomised Controlled study of Velcade (Bortezomib) plus Thalidomide plus Dexamethasone compared to Thalidomide plus Dexamethasone for the treatment of myeloma patients progressing or relapsing after autologous transplantation Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Laurent Garderet